CellProthera
PrivateLast Round
VC Round
Mar 30, 2023
Total Funding Raised
$22.64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellProthera is a biotechnology company that develops regenerative cell therapy for the structural and functional regeneration of cardiac lesions following a severe heart attack.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellProthera Comparables
Compare CellProthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioCardia Inc | 81% | |
| Bayer AG | 73% | |
| Vericel Corporation | 68% |
CellProthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 30, 2023 | ||||
| Grant | May 1, 2018 | ||||
| VC Round | Sep 3, 2014 | ||||
| Grant | Jul 11, 2013 | ||||
| Seed | Sep 1, 2009 |
Key People
Founding team and executive leadership
CellProthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Alsace Business Angels | VC Round, Seed |
| SODIV | VC Round |
| Bpifrance | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 61% MoM, reaching 1K.
- Jul 20, 2026
Open roles increased to 29, 107% of current headcount.
Recent news
Latest coverage and updates
- partners_withAug 11, 2026
CellProthera SAS partnered with Alfresa Holdings Corporation on Aug 11th '26.
CellProthera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CellProthera's valuation, stock price, and market status.
Is CellProthera a public or private company?
CellProthera is a private company.
What is the current stock price of CellProthera?
CellProthera is a private company with no public stock price. No recent secondary market data is available.
How much is CellProthera worth (valuation)?
Valuation information for CellProthera is not publicly available.
Can I buy CellProthera stock?
CellProthera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CellProthera's last funding round?
CellProthera's most recent funding round was VC Round on March 30, 2023.
Who are the main investors in CellProthera?
Key investors in CellProthera include Bpifrance.
Will CellProthera IPO soon?
No public IPO plans have been announced for CellProthera.
How can I track CellProthera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellProthera's secondary market activity and sign up for updates.